NEW YORK ( TheStreet) -- Novo Nordisk A/S (NYSE: NVO) hit a new 52-week high Tuesday as it is currently trading at $158.95, above its previous 52-week high of $158.20 with 97,243 shares traded as of 10:04 a.m. ET. Average volume has been 431,700 shares over the past 30 days. Novo Nordisk A/S has a market cap of $89.56 billion and is part of the health care sector and drugs industry. Shares are up 34.9% year to date as of the close of trading on Monday. Novo Nordisk A/S, a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products in Denmark and internationally. The company operates in two segments, Diabetes Care and Biopharmaceuticals. The company has a P/E ratio of four, below the average drugs industry P/E ratio of 27.8 and below the S&P 500 P/E ratio of 17.7.
- ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!